We demonstrated a niacin-PNPLA3 I148M interaction in NAFLD patients which possibly pave the way to vitamin B3 supplementation in those with a predisposing genetic background. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.